Related Experiment Video
Updated: Jan 9, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Analyzing Basal Insulin Dosing as Perturbations in Compositional Glycemic Profiles for Time in Range in Type 1
Abstract:
Basal insulin dosing is essential in multiple daily injection therapy for Type 1 Diabetes, yet adjustments remain challenging. This study models basal insulin changes as perturbations in Compositional Data Analysis (CoDa) to assess their impact on glycemic control. In silico simulations were conducted with a virtual cohort of 49 adults over 180 days, considering controlled meal intake and insulin therapy. Basal insulin adjustments (±5%, ±10%, ±15%) were analyzed using CoDa to assess the effects on time in range (TIR: 70-180 mg/dL) and the glycemic distribution. A multivariate linear regression model predicted outcomes based on basal adjustments. The CoDa framework quantified the impact of basal insulin perturbations on TIR, as shown by multivariate models with high R2 values (up to 0.85). Furthermore, we observed a strong correlation between a CoDa-derived log-ratio coordinate and an established glycemic risk index (r = -0.9141). A visualization panel integrates: (i) arithmetic mean TIR (clinically common), (ii) geometric mean (aligned with CoDa) and (iii) glycemic profile distributions (to describe daily variability). This improvement aids physicians in adjusting therapy.Clinical relevance- This study introduces a decision support system leveraging CoDa analysis to predict glycemic outcomes based on basal insulin adjustments. By modeling basal perturbations, the approach enables disease profiling and personalized treatment strategies, reducing the trial-and-error process in basal insulin titration and optimizing T1D management.
More Related Videos
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Dosage Regimen: Individualization
Diabetes Mellitus: Type 2 and Gestational
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

